A reliable method for rapidly determining the viability of HPCs is essential for clinical cellular engineering. The trypan blue (TB) viability assay is a widely performed procedure to assess HPC viability before and after cryopreservation and before bone marrow transfusion.
A reliable method for rapidly determining the viability of HPCs is essential for clinical cellular engineering. The trypan blue (TB) viability assay is a widely performed procedure to assess HPC viability before and after cryopreservation and before bone marrow transfusion. 1 The TB assay is based on the ability of the membrane of viable cells to exclude the dye, while nonviable cells are stained blue when viewed by light microscopy. However, the TB assay can be difficult to interpret because of staining artifacts. In addition, the TB viability assay has never been validated for use with HPCs.
Alternative viability assays using the fluorescent dyes acridine orange (AO) and propidium iodide (PI) have been developed for the simultaneous visualization of both viable and nonviable cells. 2, 3 AO is a membrane-permeable, cationic dye that binds to nucleic acids of viable cells and that at low concentrations causes a green fluorescence. PI is impermeable to intact membranes but readily penetrates the membranes of nonviable cells and binds to DNA or RNA, causing orange fluorescence. When AO and PI are used simultaneously, viable cells fluoresce green and nonviable cells fluoresce orange under fluorescence microscopy. Results of the AO/PI assay in pancreatic islet cells have been shown to correlate with those of the TB viability assay but have been easier to interpret. 4 Here we describe a rapid fluorometric assay for HPC viability using AO 
STUDY DESIGN AND METHODS:
A fluorometric cell viability assay using acridine orange and propidium iodide (AO/PI) was compared to the current standard, trypan blue (TB) exclusion. Viable cells stained with AO/ PI fluoresce green under darkfield fluorescence microscopy, while nonviable cells fluoresce orange. Mixtures of fresh and heat-killed bone marrow were prepared and used as viability standards for evaluation of both assays. The frequency of CFU-GM was determined for each specimen. RESULTS: Cell viability measured by AO/PI was extremely linear, with measured and predicted viability in agreement from 0 to 100 percent of the viable cells and a coefficient of regression (r 2 ) of 0.9921. The predictedviability regression line fell within the 95% CI for AO/PImeasured viability. The coefficient of regression for TBmeasured viability was 0.9584, with the predicted-viability regression line almost entirely outside the 95% CI. TB overestimated the percentage of viable cells, particularly below the 50-percent level. CFU-GM frequency correlated better with cell viability measured by AO/PI (r 2 = 0.979) than with that measured by TB (r 2 = 0.930).
CONCLUSIONS:
The AO/PI viability assay is a rapid, highly linear, functionally correlated assay that is superior to conventional viability measurement by TB exclusion. assay with those of the TB viability assay. Both viability assays were validated by the use of specimens of known viability and clonogenic assays for HPCs. In addition, the stability over time of the TB and AO/PI staining was determined. HPCs derived from peripheral or umbilical cord blood were not tested.
ABBREVIATIONS

MATERIALS AND METHODS
Cells
Bone marrow was collected from the posterior iliac crest of a normal donor under institutional review board approval and by using standard techniques. 5 Fresh, heparinized bone marrow was washed into minimum essential medium alpha modification (α-MEM, GIBCO, Grand Island, NY) with 1-percent HSA (Baxter-Hyland, Glendale, CA). The cell suspension was divided into two equal aliquots of 10 mL. Cells in one aliquot were heat-killed at 65°C × 15 minutes and then washed and resuspended in a total volume of 10 mL of α-MEM with 1-percent HSA. These two aliquots were measured by both the AO/PI and TB assays; the cells in the heat-killed aliquot were 100-percent nonviable, and those in the other aliquot were 100-percent viable. Cell concentrations were measured in each aliquot and adjusted to an identical value, 9.4 × 10 6 cells per mL. Calibrated automated electronic pipettors (Rainin Electronics, Woburn, MA) were used to prepare seven 1-mL cell suspensions from these two stock aliquots. The suspensions represented predicted percentages (0, 5, 25, 50, 75, 95, and 100%) of viable cells. Cell viability for each of these seven aliquots was evaluated by both TB exclusion and AO/ PI staining. The percentage of viable cells was calculated as the average of five viability measurements, each of which required the scoring of 100 cells. Measurements were repeated five times to assess the reproducibility of viability measurement. Measurements were performed by two individuals.
Assays
TB viability measurement was performed by standard methods.
1 TB solution (0.4% wt/vol, GIBCO) was mixed with each of the seven predicted-viability aliquots, using 190 µL of stain to 10 µL of cell suspension. The suspension was loaded into a Neubauer hemocytometer and scored with a Zeiss compound light microscope at 250×. Cells that stained blue were scored as nonviable.
Cell viability was evaluated by AO/PI staining as previously described by Banks.
2,4 AO/PI stock solution was prepared as 1 mM AO and 1 mM PI in PBS (Sigma Chemical Co., St. Louis, MO). Samples of each of the predicted-viability aliquots (10 µL) were mixed with 190 µL of AO/PI stock solution. The suspension was loaded into a Neubauer hemocytometer and scored with a Zeiss compound fluorescence microscope at 250×. Cells fluorescing green were scored as viable. Cells fluorescing orange, either fully or partially, were scored as nonviable.
Progenitor assays were performed on each predictedviability specimen by using serum-free methylcellulose progenitor assay medium (MethoCult GF HC4434, Stem Cell Technologies, Vancouver, BC, Canada) and a standardized progenitor assay method. 6 One person performed all progenitor assays. Cells were suspended in the MethoCult medium and plated in duplicate 35-mm culture dishes at each of two plating concentrations, 2.5 × 10 4 and 5.0 × 10 4 nucleated cells per plate, with 1.1 mL dispensed per plate.
Plates were incubated at 37°C in a humidified 5-percent CO 2 incubator for 14 days. CFU-GM were counted with a stereomicroscope (SZH-ILLD, Olympus Precision Instruments, Melville, NY) at 40× power. The plating concentration giving optimal growth and readability was selected for each pair of duplicate plates, and the mean concentration of CFU-GM per 10 5 nucleated cells was calculated. The stability of the TB and AO/PI viability assays over time was determined by repeated measurement of the percentage of viable cells in a single, fresh marrow specimen over 120 minutes. Two cell suspensions were stained with TB and AO/PI, respectively, by the methods described above. The percentage of viable cells was measured at 10-minute intervals over 60 minutes and at 15-minute intervals over an additional 60 minutes.
Statistical methods
Software programs (Excel for Windows 95, version 7.0, Microsoft, Redmond, WA; SigmaPlot for Windows, version 3.06, SPSS , Chicago, IL) were used for data analysis. Viability measurements performed by each method were analyzed by linear regression, regression coefficients were compared with the ideal values of 0 and 1, and 95% CIs were determined.
RESULTS
The percentage of viable cells measured by TB exclusion for the controlled-viability specimens is depicted in Fig. 1 The percentage of viable cells measured with AO/PI is shown in Fig. 2 . Viability measured by AO/PI was extremely linear, with measured and predicted viability consistently in agreement for the entire range of viability measurement, from 0 to 100 percent. The linear regression equation for AO/PI measured viability was y = 1.009× + 2.148, with r 2 = 0.9921. Slope and intercept of this regression line were not significantly different from 1 and 0, respectively, and the regression line for predicted viability fell within the 95% CI. The CV for the five viability measurements performed on each specimen ranged from 1.3 to 68.8 percent.
The results of both TB and AO/PI viability assays were compared with the frequency of CFU-GM (the actual number of colonies grown from each of the two plating concentrations), a measure of HPC function. Figure 3 
DISCUSSION
A simple, reliable, and reproducible assay for HPC viability is essential for clinical cellular engineering laboratories. Traditionally, the TB dye exclusion assay has been used to determine cell viability before and after cryopreservation and before cell transfusion, but the TB assay can be difficult to read and interpret. Moreover, despite widespread use, validation studies of the TB assay have not been published. The AO/PI assay, with its two fluorescent dyes viewed under darkfield fluorescence microscopy, permits clear differentiation of viable and nonviable cells. The AO/PI assay has a higher degree of linearity and its results more closely resemble predicted viability than those of the TB assay. The TB assay was particularly problematic at lower percentages of cell viability. At 5-percent and 25-percent predicted viability, the TB viability measurements were 29.9 percent and 55.3 percent, respectively. Although most clinical specimens contain a higher percentage of viable cells, some extensively manipulated specimens can fall within this range. This overestimation of viability measurements by the TB assay can have clinical implications.
The percentage of viable cells measured with the AO/ PI assay showed better correlation with CFU-GM frequency than did that measured by TB (r 2 = 0.979 and r 2 = 0.930, respectively). The TB assay overestimated progenitor cell function as measured by CFU-GM concentration. Clinical laboratories typically test specimens for cell viability more often than for CFU-GM frequency; it is helpful, therefore, to use a viability assay that correlates well with HPC assay results. One reason that cell viability measured with AO/PI so closely correlated with predicted viabilities and CFU-GM concentration may be the assay's greater readability and more accurate interpretation. With the high background of RBCs and debris as well as the variable staining or shading of cells, readability and scoring of cells with the TB assay can be ambiguous. In the AO/PI assay, RBCs and debris are not visible during darkfield microscopy, the cellular detail and nuclear outline are distinct, and the simultaneous use of two dyes allows for clear differentiation of viable and nonviable cells. With AO/PI, therefore, there is no need to remove RBCs by lysis or ficoll density gradient centrifugation. Both assays are rapid and easy to perform, although the AO/PI assay requires a fluorescence microscope. We believe the increased accuracy of results and ease of interpretation more than compensate for the need for fluorescence microscopy.
TB is toxic to cells over time and affects the stability of TB-stained cells.
1 By contrast, the AO/PI assay has previously been described as being stable over time, and AO/PI is nontoxic to isolated islet cells. 2 A perfectly stable assay would have a linear regression slope of 0 over time. The linear regression equation slope for bone marrow cells stained with AO/PI was -0.0063 over 2 hours, which indicates an extremely stable assay. TB-measured viability was less stable over time. The stability of the AO/PI assay permits staining and scoring of multiple specimens in batches and also is helpful in training staff.
The AO/PI viability assay is a simple, rapid, highly linear, functionally correlated assay that is superior to the conventional TB viability assay. The AO/PI assay has not, however, been validated with other HPCs, such as those derived from peripheral or umbilical cord blood.
